IL4R and glioblastoma: A combination of pulsed HIFU and atherosclerotic plaque-specific peptide-1 (AP-1)-conjugated liposomes that contain doxorubicin and that specifically bind to the interleukin 4 receptor (IL-4R) worked to elevate the tumor-to-brain drug ratio in a xenografted GBM model [50-52].